Myanmar Protesters Swap New Year Blessings for Anti-Junta Statements

With little to celebrate as they kicked off the Burmese New Year on Tuesday, people across Myanmar staged holiday-themed protests to defy the military junta in what an activist called “a funeral wake for the whole country,” while the U.N. rights chief said she feared the nation faces a fate similar to war-shattered Syria. Opponents […]

Nikkiso Cryo Inc. New Facility Increases Cryogenic Pump Production

LAS VEGAS, April 13, 2021 (GLOBE NEWSWIRE) — Nikkiso Cryo Inc. (NCI), Las Vegas NV, a member of Nikkiso Clean Energy and Industrial Gases Group (Group), a part of Nikkiso Co., Ltd (Japan) announces their new facility which increases their cryogenic pump production efficiency and capability. NCI’s new, larger facility was necessary due to continued […]

Tim Born becomes Vice President, Oceania and South East Asia for Nikkiso Clean Energy & Industrial Gases Group

TEMECULA, Calif., April 13, 2021 (GLOBE NEWSWIRE) — Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a subsidiary of Nikkiso Co., Ltd (Japan), is pleased to announce that Tim Born has been appointed as the Vice President of Oceania and South East Asia Region. This important addition to our management team is in […]

Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis platform expansion in Asia

Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis platform expansion in Asia Cambridge, United Kingdom and Singapore – 13 April 2021– Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a strategic partnership with Camtech Diagnostics (“Camtech”), a technology company providing […]

Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the American Association for Cancer Research 2021 Annual Meeting

 PRESS RELEASE Immunocore presents phase 3 data comparing tebentafusp with investigator’s choice in the clinical trial plenary session at the  American Association for Cancer Research 2021 Annual Meeting Tebentafusp is the first investigational therapy to improve Overall Survival (OS) in patients with metastatic uveal melanoma First positive Phase 3 clinical trial for any T cell […]